Insights from 2023 ASH Annual Meeting
Playback speed
10 seconds
ASH 2023 Insights: "Revumenib Maintenance Therapy Following Revumenib-Induced Remission & Transplant in Acute Leukemias"
By
Insights from 2023 ASH Annual Meeting
FEATURING
Andrius Zucenka
By
Insights from 2023 ASH Annual Meeting
FEATURING
Andrius Zucenka
59 views
December 18, 2023
Login to view comments.
Click here to Login
Leukemia